Vertex Pharmaceuticals Inc (VRTX) — Cash Flow Quality Index
Vertex Pharmaceuticals Inc (VRTX) has a Cash Flow Quality Index of 1.38x as of March 2026. Operating cash flow of $1.43 Billion exceeds net income of $1.03 Billion, indicating high earnings quality where cash backs reported profits. Explore Vertex Pharmaceuticals Inc (VRTX) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Vertex Pharmaceuticals Inc Cash Flow Quality Index (1993–2025)
Historical Cash Flow Quality Index for Vertex Pharmaceuticals Inc across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check VRTX goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Vertex Pharmaceuticals Inc (1993–2025)
Year-by-year earnings quality comparison for Vertex Pharmaceuticals Inc. For live market cap and the full company financial profile, see Vertex Pharmaceuticals Inc market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.92x | $3.63 Billion | $3.95 Billion | ▼ -6.0% |
| 2023 | 0.98x | $3.54 Billion | $3.62 Billion | ▼ -21.4% |
| 2022 | 1.24x | $4.13 Billion | $3.32 Billion | ▲ +10.1% |
| 2021 | 1.13x | $2.64 Billion | $2.34 Billion | ▼ -5.9% |
| 2020 | 1.20x | $3.25 Billion | $2.71 Billion | ▼ -10.0% |
| 2019 | 1.33x | $1.57 Billion | $1.18 Billion | ▲ +119.1% |
| 2018 | 0.61x | $1.27 Billion | $2.09 Billion | ▼ -93.4% |
| 2017 | 9.22x | $844.94 Million | $91.64 Million | ▲ +164.2% |
| 2011 | 3.49x | $143.74 Million | $41.18 Million | ▼ -18.8% |
| 1993 | 4.30x | $8.60 Million | $2.00 Million | — |